Indication

Invasive pulmonary aspergillosis

Invasive pulmonary aspergillosis is a severe, life-threatening opportunistic fungal infection of the lower respiratory tract caused by the inhalation of airborne spores from *Aspergillus* species, most commonly *Aspergillus fumigatus*. Read more about Invasive pulmonary aspergillosis

69 drugs 49 manufacturers

Advertisement

Drugs that treat it

Common Invasive pulmonary aspergillosis therapies.

Showing 55–63 of 69 drugs

VORICONAZOLE

ANTIFUNGALS-SYSTEMIC·DISSEMINATED CANDIDIASIS·+6
FOSUN PHARMA US

POSACONAZOLE

ANTIFUNGALS-SYSTEMIC·PREVENTION OF DISSEMINATED CANDIDIASIS·+2
I3 PHARMACEUTIC

VORICONAZOLE

ANTIFUNGALS-SYSTEMIC·DISSEMINATED CANDIDIASIS·+6
CIVICA, INC.

POSACONAZOLE

ANTIFUNGALS-SYSTEMIC·PREVENTION OF DISSEMINATED CANDIDIASIS·+2
A2A INTEGRATED

POSACONAZOLE

ANTIFUNGALS-SYSTEMIC·PREVENTION OF DISSEMINATED CANDIDIASIS·+2
MYLAN INSTITUTI

POSACONAZOLE

ANTIFUNGALS-SYSTEMIC·PREVENTION OF DISSEMINATED CANDIDIASIS·+2
GLENMARK-NOVAPL

POSACONAZOLE

ANTIFUNGALS-SYSTEMIC·PREVENTION OF DISSEMINATED CANDIDIASIS·+2
SpecGx

POSACONAZOLE

ANTIFUNGALS-SYSTEMIC·PREVENTION OF DISSEMINATED CANDIDIASIS·+2
Amneal Pharmaceuticals

POSACONAZOLE

ANTIFUNGALS-SYSTEMIC·PREVENTION OF DISSEMINATED CANDIDIASIS·+2
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Invasive pulmonary aspergillosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Invasive pulmonary aspergillosis.

Invasive pulmonary aspergillosis is a severe, life-threatening opportunistic fungal infection of the lower respiratory tract caused by the inhalation of airborne spores from *Aspergillus* species, most commonly *Aspergillus fumigatus*.

It primarily develops in severely immunocompromised individuals—such as patients with prolonged neutropenia, hematologic malignancies, or hematopoietic stem cell and solid organ transplants—as well as critically ill patients with severe viral pneumonia.

Pathophysiologically, the organism invades the bronchial mucosa and surrounding pulmonary parenchyma, exhibiting a characteristic hallmark of angioinvasion that leads to thrombosis, tissue necrosis, pulmonary infarction, and potential hematogenous dissemination.

Patients typically present with fever, cough, dyspnea, pleuritic chest pain, and hemoptysis, often accompanied by characteristic macronodules with surrounding ground-glass attenuation on chest imaging.

Personalize your experience

Follow Invasive pulmonary aspergillosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it